Stratasys, Ltd.(NASDAQ:SSYS) shares are up more than 4% in afternoon trading Monday after the provider of 3D printing and additive manufacturing solutions said Brightwake has developed a blood recycling machine using its 3-D printer technology.
The shares also got a boost from news Goldman Sachs has initiated coverage with a Buy rating and a $146 price target.
The Hemosep recovers blood spilled during open heart and major trauma surgery, concentrating the blood cells ready for transfusion back into the patient. Brightwake said the 3-D printing technology enabled the company to cut time and costs. The shares recently traded at $98.51 in a 52-week range of $69.60 – $138.10.
Analysts have a consensus price target of $140 on Stratasys, Ltd.(NASDAQ:SSYS) which indicates a 49% upside. The consensus rating of the stock is a BUY with a score of 2.84. There are currently 16 Buy ratings and 3 Hold ratings on the stock.
A recent analyst action consisted of UBS boosting their price target from $125 to $130.
Suggested Reading: Most Important Medical Advances